Validation of the Ottawa prognostic score for the prediction of recurrent venous thromboembolism in patients with cancer-associated thrombosis

被引：42
作者：
Den Exter, P. L. [1 ]
Kooiman, J. [1 ]
Huisman, M. V. [1 ]
机构：
[1] Leiden Univ, Med Ctr, Dept Thrombosis & Hemostasis, NL-2300 RC Leiden, Netherlands
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2013年 / 11卷 / 05期
关键词：
PULMONARY-EMBOLISM; RISK;
D O I：
10.1111/jth.12192
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：998 / 1000
页数：3
相关论文
共 9 条
[1]   Malignancies, prothrombotic mutations, and the risk of venous thrombosis [J].
Blom, JW ;
Doggen, CJM ;
Osanto, S ;
Rosendaal, FR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (06) :715-722
[2]  
Buller HR, 2007, NEW ENGL J MED, V357, P1094
[3]   Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trial [J].
Buller, Harry R. ;
Gallus, Alex S. ;
Pillion, Gerard ;
Prins, Martin H. ;
Raskob, Gary E. .
LANCET, 2012, 379 (9811) :123-129
[4]   Vitamin K antagonists versus LMWH in the treatment of venous thromboembolism in patients with malignancy: an observational survey in daily clinical practice [J].
den Exter, P. L. ;
Hooijer, J. ;
Dekkers, O. M. ;
Huisman, M. V. .
THROMBOSIS RESEARCH, 2012, 129 :S183-S184
[5]   Risk factors for deep vein thrombosis and pulmonary embolism -: A population-based case-control study [J].
Heit, JA ;
Silverstein, MD ;
Mohr, DN ;
Petterson, TM ;
O'Fallon, WM ;
Melton, LJ .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (06) :809-815
[6]   Antithrombotic Therapy for VTE Disease Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence- Based Clinical Practice Guidelines [J].
Kearon, Clive ;
Akl, Elie A. ;
Comerota, Anthony J. ;
Prandoni, Paolo ;
Bounameaux, Henri ;
Goldhaber, Samuel Z. ;
Nelson, Michael E. ;
Wells, Philip S. ;
Gould, Michael K. ;
Dentali, Francesco ;
Crowther, Mark ;
Kahn, Susan R. .
CHEST, 2012, 141 (02) :E419S-+
[7]   Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer [J].
Lee, AYY ;
Levine, MN ;
Baker, RI ;
Bowden, C ;
Kakkar, AK ;
Prins, M ;
Rickles, FR ;
Julian, JA ;
Haley, S ;
Kovacs, MJ ;
Gent, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (02) :146-153
[8]   Development of a Clinical Prediction Rule for Risk Stratification of Recurrent Venous Thromboembolism in Patients With Cancer-Associated Venous Thromboembolism [J].
Louzada, Martha L. ;
Carrier, Marc ;
Lazo-Langner, Alejandro ;
Dao, Vi ;
Kovacs, Michael J. ;
Ramsay, Timothy O. ;
Rodger, Marc A. ;
Zhang, Jerry ;
Lee, Agnes Y. Y. ;
Meyer, Guy ;
Wells, Philip S. .
CIRCULATION, 2012, 126 (04) :448-454
[9]   Risk of recurrent venous thromboembolism according to malignancy characteristics in patients with cancer-associated thrombosis: a systematic review of observational and intervention studies [J].
Louzada, Martha L. ;
Majeed, Habeeb ;
Dao, Vi ;
Wells, Philip S. .
BLOOD COAGULATION & FIBRINOLYSIS, 2011, 22 (02) :86-91
1